Power Law company profile

Cellectis

Biotech & Life Sciences · Paris, France · Founded 1999 · IPO 2007 Unicorn

Developing allogeneic CAR-T cells

Valuation

$257M

Market cap · May/2026

Revenue

$73M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

7 investors on Cellectis's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage

Institut Pasteur

Odyssée Venture

Andera Partners

BankInvest

HEC Paris

Eurazeo

HEC Challenge+

Cellectis mafia

Startups founded by Cellectis alumni

Former Cellectis employees who went on to start their own companies. Sorted by Dealroom signal score.

Standing OvationEst. 2020

Frédéric PâquesFrance

Signal score83

ArzedaEst. 2008

Alexandre ZanghelliniUnited States

TZThierry ZieglerFrance

Signal score73

Generation BioEst. 2016

ASAndy ScharenbergUnited States

Signal score62

Mnemo TherapeuticsEst. 2019

Justin EyquemFrance

Signal score0

Book a demo to explore the full alumni network →

Global footprint

Where Cellectis has talent and traffic

AI talent share

0.4% of workforce is AI talent
(1 of 237 staff)

Core AI00%

Other AI10.42%

Non-AI workforce23699.58%

Workforce by country

9 countries with
team presence

🇫🇷 France61.2%

🇺🇸 United States35.7%

🇩🇪 Germany0.5%

🇨🇦 Canada0.5%

🇬🇧 United Kingdom0.5%

Top 5 of 9 shown

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States59.1%

🇫🇷 France16.4%

🇬🇧 United Kingdom8.2%

🇪🇸 Spain7.3%

🇧🇪 Belgium4.5%

Top 5 markets shown

Patent intelligence

$157M patent portfolio · 98 active families

Estimated portfolio value

$157M

61.1% of market cap · 5× smaller than top peer BioNTech ($780M)

98 active patent families

Where Cellectis innovates Molecular biologyNucleaseMeganucleaseCell biologyImmunology

Where Cellectis concentrates vs peers

Each axis is a top-10 topic across Cellectis and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Cellectis

An AI-synthesized read of the highest-engagement posts about Cellectis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cellectis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles